Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group.

Wilma M. Hopman(Queen's University), Emmanuel Papadimitropoulos(Eli Lilly (Canada)), Jacques P. Brown(Centre hospitalier de l'Université Laval), Alan Tenenhouse(St. Vincent's Birmingham), Tassos Anastassiades, Suzette Poliquin, L. Joseph(McGill University Health Centre), David A. Hanley(University of Calgary), J.D. Adachi, Claudie Berger(McGill University Health Centre), Timothy M. Murray(Beaumont Hospital), Tanveer Towheed
PubMed
August 8, 2000
Cited by 693

Related Papers

Body mass index as a predictor of fracture risk: A meta-analysis
|Osteoporosis International|2005|1.6k
Predictive Value of BMD for Hip and Other Fractures
|Journal of Bone and Mineral Research|2005|1.5k
A meta-analysis of previous fracture and subsequent fracture risk
|Bone|2004|1.3k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
|Osteoporosis International|2007|1.2k